Jump to content
RemedySpot.com

RESEARCH - Local botulinum toxin type A injections in the treatment of spastic toes

Rate this topic


Guest guest

Recommended Posts

Guest guest

Local Botulinum Toxin Type A Injections in the Treatment of Spastic Toes.

American Journal of Physical Medicine & Rehabilitation. 81(10):770-775,

October 2002.

Suputtitada, Areerat MD

Abstract:

Suputtitada A: Local botulinum toxin type A injections in the treatment of

spastic toes. Am J Phys Med Rehabil 2002;81:770-775.

Objective: To investigate the efficacy and safety of botulinum toxin type

A treatment of spastic toes using varying doses based on the degree of

spasticity (Modified Ashworth Scale).

Design: Single-center, open-label, prospective study. Hemiplegic patients

with either hitchhiker's great toes (persistent extension of the great toes)

or toe flexor spasms with pain during walking were treated with local

intramuscular injections of botulinum toxin type A. Initial botulinum toxin

type A dose per muscle was 25 units for patients with a baseline Ashworth

score of 2, 50 units for a score of 3, and 75 units for a score of 4.

Additional botulinum toxin type A injections were allowed if there was an

insufficient clinical response to initial treatment. The muscles injected

included flexor digitorum, extensor hallucis longus, and/or flexor hallucis

longus. All injections were made using electromyographic guidance. Outcome

measures were the Modified Ashworth Scale, a visual pain scale, a visual

percentage of function scale, and adverse effects.

Results: Twenty patients were enrolled. The dose of botulinum toxin type A

used ranged from 25 to 35 units per muscle for an Ashworth score of 2, from

50 to 70 units per muscle for a score of 3, and from 75 to 95 units per

muscle for a score of 4. There were improvements in all outcome measures. In

most patients, the benefits lasted 5-6 mo, with a few patients exhibiting

benefits for >=2 yr. There were no adverse effects.

Conclusions: Botulinum toxin type A treatment using doses based on

spasticity severity seems to be safe and effective in the treatment of

spastic toes, and further study is warranted.

© 2002 Lippincott & Wilkins, Inc.

Not an MD

I'll tell you where to go!

Mayo Clinic in Rochester

http://www.mayoclinic.org/rochester

s Hopkins Medicine

http://www.hopkinsmedicine.org

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...